FDA Adverse Event Injury Summary report: N

ENDEAVOR RX CORONARY STENT SYSTEM

MDR report key: 1850921 · Received September 29, 2010

Report

Report Number
2953200-2010-01846
Event Type
Injury
Date Received
September 29, 2010
Date of Event
October 23, 2009
Report Date
September 15, 2016
Manufacturer
MEDTRONIC CARDIOVASCULAR GALWAY
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION, RESULTS: CVA/STROKE.

Additional Manufacturer Narrative · 1

PATIENT HAS A HISTORY OF PRIOR PVD. CARDIAC STATUS WAS ACUTE CORONARY SYNDROME (UNSTABLE ANGINA) AT TIME OF INDEX PROCEDURE. DURING THE INDEX PROCEDURE THREE ENDEAVOR STENT WERE IMPLANTED ONE IN THE PROX CX, ONE IN THE RAMUS AND ONE IN THE 1ST OB MAR VESSELS. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

CORRECTED INFORMATION: DATE OF BIRTH. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

THE PHYSICIAN SUCCESSFULLY DEPLOYED A 2.5MM DIAMETER X 24MM LENGTH ENDEAVOR RAPID EXCHANGE (RX) DRUG-ELUTING STENT AT CASS#12 (REF MFR# 2953200-2010-01844). TWO OTHER ENDEAVOR RX STENTS WERE IMPLANTED DURING THE SAME PROCEDURE (REF MFR# 2953200-2010-01845). REMAINING STENOSIS WAS 0%. IVUS CONFIRMED THAT THE STENTS WERE APPOSED ON THE VESSEL WALL. FOUR DAYS POST INDEX PROCEDURE, THE PT SUFFERED A CEREBRAL ISCHEMIC STROKE RESULTING IN IMPAIRMENT. IN THE INVESTIGATOR'S OPINION, THERE WAS NO RELATIONSHIP BETWEEN THE EVENT AND THE PRODUCT OR THE DRUG. AT 30 DAYS, 6 MONTH AND 9 MONTH FOLLOW-UP, CONFIRMED NO ADVERSE EVENTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR RX CORONARY STENT SYSTEM STENT, CORONARY, DRUG-ELUTING NIQ MEDTRONIC CARDIOVASCULAR GALWAY NA UNK

Patients

Seq Age Sex Outcome Treatment
1 78 YR Hospitalization| L| S CLOPIDOGREL